Medicinal Chemistry Profiling of Monocyclic 1,2-Azaborines
- PMID: 28181424
- PMCID: PMC5654323
- DOI: 10.1002/cmdc.201700047
Medicinal Chemistry Profiling of Monocyclic 1,2-Azaborines
Abstract
The first examples of biologically active monocyclic 1,2-azaborines have been synthesized and demonstrated to exhibit not only improved in vitro aqueous solubility in comparison with their corresponding carbonaceous analogues, but in the context of a CDK2 inhibitor, also improved biological activity and better in vivo oral bioavailability. This proof-of-concept study establishes the viability of monocyclic 1,2-azaborines as a novel pharmacophore with distinct pharmacological profiles that can help address challenges associated with solubility in drug development research.
Keywords: BN heterocycle; CDK2 inhibitors; azaborines; drug discovery; solubility.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figures
References
-
- Nicolaou KC, Hale CRH, Nilewski C, Ioannidou HA. Chem. Soc. Rev. 2012;41:5185–5238. - PMC - PubMed
- Wright PM, Seiple IB, Myers AG. Angew. Chem. Int. Ed. 2014;53:8840–8869. - PMC - PubMed
- Angew. Chem. 2014;126:8984–9014.
- Rodrigues T, Reker D, Schneider P, Schneider G. Nat. Chem. 2016;8:531–541. - PubMed
-
-
For an overview, see: Liu Z, Marder TB. Angew. Chem. Int. Ed. 2008;47:242–244.Angew. Chem. 2008;120:248–250.Bosdet MJD, Piers WE. Can. J. Chem. 2009;87:8–29.Campbell PG, Marwitz AJV, Liu S-Y. Angew. Chem. Int. Ed. 2012;51:6074–6092.Angew. Chem. 2012;124:6178–6197..
-
-
- Roughley SD, Jordan AM. J. Med. Chem. 2011;54:3451–3479. - PubMed
-
- McGrath NA, Brichacek M, Njardarson JT. J. Chem. Ed. 2010;87:1348–1349.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
